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Abstract
Background:  Angiotensin converting enzyme (ACE) is a possible candidate gene that may
influence both body fatness and blood pressure. Although several genetic studies have been
conducted in adults, relatively few studies have examined the contribution of potential candidate
genes, and specifically ACE I/D, on adiposity and BP phenotypes in childhood. Such studies may
prove insightful for the development of the obesity-hypertension phenotype early in life. The
purpose of this study was to examine differences in body fatness and resting blood pressure (BP)
by ACE I/D genotype, and determine if the association between adiposity and BP varies by ACE I/
D genotype in children.
Methods: 152 children (75 girls, 77 boys) were assessed for body composition (% body fat) using
dual energy x-ray absorbtiometry and resting BP according to American Heart Association
recommendations. Buccal cell samples were genotyped using newly developed PCR-RFLP tests for
two SNPs (rs4341 and rs4343) in complete linkage disequilibrium with the ACE I/D polymorphism.
Partial correlations were computed to assess the ociations between % body fat and BP in the total
sample and by genotype. ANCOVA was used to examine differences in resting BP by ACE I/D
genotype and fatness groups.
Results: Approximately 39% of youth were overfat based on % body fat (>30% fat in girls, 25% fat
in boys). Body mass, body mass index, and fat-free mass were significantly higher in the ACE D-
carriers compared to the II group (p < 0.05). BP was not significantly different by ACE I/D
genotypes. In the total sample, correlations between adiposity and BP ranged from 0.30 to 0.46,
and were not significantly different between genotypes. When grouped by genotype and body fat
category, the overfat D-carrier subjects had significantly higher SBP and MAP compared to the
normal fat D-carrier and normal fat II groups (p < 0.05).
Conclusion: ACE D-carriers are heavier than ACE II children; however, BP did not differ by ACE
I/D genotype but was adversely influenced in the overfat D-carriers. Further studies are warranted
to investigate the genetics of fatness and BP phenotypes in children.
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Introduction
Currently, there is considerable interest in the genetics of
complex human phenotypes such as obesity and hyper-
tension. The estimated heritability of adiposity measures
range from 25–40% [1] and several candidate genes have
been identified for obesity phenotypes [2]. The heritabil-
ity of blood pressure (BP) phenotypes is estimated to be
about 30% [1]. A recent genomic scan showed that a
number of chromosomal regions have been identified for
the phenotypic expression of BP [3]. Although some of
these chromosomal regions are specific to BP, other
regions also involve genes related to obesity which sug-
gests pleiotropy. An earlier study of children also indi-
cated that a major gene may affect both body mass index
and BP [4].
Angiotensin converting enzyme (ACE) is a possible candi-
date gene that may have pleiotropic effects. ACE is an
important regulatory enzyme of the renin-angiotensin-
aldosterone (RAA) system, which is a complex system that
plays a critical role in maintaining blood pressure home-
ostasis. ACE converts inactive angiotensin I into active
angiotensin II (vasoconstrictor) and inactivates bradyki-
nin and kallidin (vasodilators). Thus, activation of the
RAA system results in a vasopressor response mainly
through the actions of ACE. The ACE gene is located at
17q23 and contains a polymorphism distinguished by
either an insertion (I) or deletion (D) of a 287 base pair
segment in intron 16. The ACE DD genotype has been
associated with higher levels of ACE [5], BP [3,6-8], fat-
ness [2], and increased cardiovascular risk [5]. Although
several genetic studies have been conducted in adults, rel-
atively few studies have examined the contribution of
potential candidate genes, and specifically ACE I/D, on
adiposity and BP phenotypes in childhood [9-13]. Such
studies may prove insightful for the development of the
obesity-hypertension phenotype early in life.
It is well-known that a positive relationship exists between
several measures of body size and adiposity (e.g., body
mass index, skinfold thickness, etc.) and BP across the
lifespan [14]. Similar to other papers, we showed that fat-
ness was significantly related to BP in children, and the
differences were most pronounced at the extremes (nor-
mal weight vs. overweight) as indicated by a 3.5 times
odds of having elevated BP in overweight compared to
normal weight youth [15]. Similar to other studies, there
was considerable variation in BP among individuals with
similar levels of adiposity. It thus seems reasonable to
hypothesize that genetic factors modulate the relationship
between adiposity and BP [16]. Indeed, recent studies in
adults indicate that specific genetic markers modify the
relationship between adiposity and BP [7,17,18]. In a pre-
vious paper, we found that a positive family history of cor-
onary heart disease (CHD) did not modify the
relationship between adiposity and BP in young children
[15]. In this study, we replace self-reported family history
of CHD with the ACE I/D genotype.
Given the paucity of studies in this emerging area of
research, the purpose of this study was to twofold: 1)
examine the differences in adiposity and BP between ACE
I/D genotypes among young children, and 2) examine if
the association between adiposity and BP was modified
by the ACE I/D genotype.
Methods
Participants
The participants in the study were young children (n =
152, 75 females, 77 males; 86% Caucasian) ages 3–12
years from a rural U.S. Midwestern community (pop.
30,000). The participants were recruited through written
and/or verbal advertisements. Parental consent was
obtained from all participants, and the procedures were
also explained to the child participants. The study proto-
col was approved by the University of Nebraska at Kear-
ney Institutional Review Board.
Anthropometry
Stature and body mass were measured according to stand-
ard procedures [19]. Stature was measured to the nearest
0.1 cm using a wall stadiometer, and body mass was
measured to the nearest 0.1 kg using a standard balance
beam scale. The body mass index (BMI) was calculated
using the following equation: body mass in kg/stature in
m2.
Dual energy x-ray absorbtiometry (DXA)
Whole-body DXA scans were performed with the subject
in light clothing while lying supine using a Lunar DPX-L
densitometer (Lunar Radiation Corporation, Madison,
WI, USA). Percent body fat (%BF), fat mass (FM) and fat-
free mass (FFM) were determined using the pediatric
medium scan mode (software version 1.5d). The Lunar
DPX-L densitometer has previously been cross-validated
using the pig carcass in the pediatric weight range [20].
Reliability between scans was achieved using a phantom
calibration.
In addition to using the continuous variable of fatness in
the statistical analysis, children were classified into one of
two groups (normal fat or overfat) based on the cut-points
for % body fat used in the FITNESSGRAM test assessment
program [21] as determined by a previous study which
linked these cut-points for body fatness with significant
risk for elevated BP and other CVD risk markers [22].
These cut-points correspond to body fat ≥25% in boys and
≥30% in girls as overfat, and <25% and <30% in boys and
girls, respectively, as normal fat.Cardiovascular Diabetology 2009, 8:14 http://www.cardiab.com/content/8/1/14
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Measurement of blood pressure
Resting BP was measured in accordance with standard
procedures and recommendations [23]. Appropriate cuff
size was determined by measuring the circumference of
the right upper arm at its largest point. Resting systolic
(SBP) and diastolic (DBP) blood pressures were measured
by auscultation after the subject was seated for 10 min-
utes. The mean arterial pressure (MAP) was calculated as:
(SBP-DBP/3) + DBP. Three measurements were taken at 1-
minute intervals, and the mean of the three values were
used for data analysis. Each technician was trained by the
same investigator (KH).
ACE I/D gene polymorphism
Two single nucleotide polymorphisms (SNP), rs4341 and
rs4343, previously found to be in complete linkage dise-
quilibrium with the ACE I/D polymorphism were selected
to design polymerase chain reaction-restriction fragment
length polymorphisms (PCR-RFLP) [24]. This method
was chosen because previous work in our lab has shown
that conventional PCR methods (including those by Rigat
et al. [5] and Shanmugam et al. [25]) and a new deletion-
specific PCR amplification test (developed by Glenn et al.
[24]) gave inconsistent results in our sample. Specifically,
there were a total of 114 genotypes that were considered
consistent for the ACE I/D, and 43 were determined to be
problematic using these methods.
Buccal cell samples were collected from participants using
Whatman sterile foam tipped applicators and Whatman
Indicating FTA®  cards and prepared for DNA analysis
according to manufacturer's instructions [26]. With the
assistance of the Whatman technical support services, the
decision was made to switch the final rinse of the punch
from TE-1 buffer to water in an attempt to prevent any
inhibition of the PCR by ethylenediamine tetraacetic acid.
The PCR amplifications were implemented using one 2.0
mm punch from a Whatman Indicating FTA® card, 1 ×
GoTaq PCR buffer, 0.125 mM of each dNTP, 0.25 mM of
each primer and 0.25 U GoTaq DNA polymerase
(Promega, Madison, WI, USA) in a 10 μl reaction volume.
The PCR conditions were as follows, 94°C for 3 min, 35
cycles of 94°C 30 sec, annealing for 30 sec and 72°C 30
sec, and a final extension at 72°C for 5 min in a PTC 200
thermocycler (MJ Research, Watertown, MA, USA).
Methodology including annealing temperatures, genomic
locations and primer sequences of ACE I/D and SNPs, as
well as the restriction enzymes and their fragment sizes for
PCR-RFLP tests and determination of ACE I/D genotype
can be found elsewhere [24]. Digestions were performed
according to the manufacturer's instructions (New Eng-
land Biolabs, Beverly, MA, USA), and the resulting frag-
ments were separated by electrophoresis on agarose gel
and visualized using ethidium bromide and UV light.
Haploview was used to analyze the ACE I/D and SNP gen-
otypes and to determine Hardy-Weinberg (HW) equilib-
rium status [27]. The combinations of SNP genotypes
used to determine ACE I/D genotype were as follows: DD:
rs4341 G/G polymorphism and rs4343 G/G polymor-
phism; ID: rs4341 C/G polymorphism and rs4343 A/G
polymorphism; II: rs4341 C/C polymorphism and rs4343
A/A polymorphism.
Statistical analysis
Descriptive statistics were calculated for all variables. Sex
differences were examined by independent t-test for con-
tinuous variables. Analysis of covariance (ANCOVA), con-
trolling for age and sex, was used to examine differences
in adiposity; and controlling for age, sex, and height to
examine differences in BP variables across genotypes.
These covariates were chosen since we included males and
females in the analytic sample and the sample varied in
age (3–12 years old). Height was included as a covariate
in the analysis concerning BP since it is known to influ-
ence BP independent of age and sex. Post-hoc tests were
performed to detect specific genotype group differences
when a significant main effect for genotype was found
from the one-way ANCOVA. The associations between
adiposity and BP were examined using partial correlation
coefficients, controlling for chronological age, sex, and
height. The difference in the magnitude of the correlations
between genotypes was tested using the Fischer z-transfor-
mation.
To test the combined influence of ACE I/D genotype (II or
D carrier) and body fatness (normal fat or overfat as pre-
viously defined) on BP, four groups were created: ACE II
genotype and normal fat, ACE II and overfat, ACE D carri-
ers and normalfat, and ACE D carriers and overfat. To test
the combined influence, a one-way ANCOVA was con-
ducted with BP measures (SBP, DBP, MAP) as the depend-
ent variable testing for the main effect of combined
genotype/body fatness group while controlling for the
covariates age, sex, and height. Post-hoc tests were per-
formed to detect specific genotype/fatness group differ-
ences when a significant main effect for combined
genotype/body fatness was found from the one-way
ANCOVA. A p-value of 0.05 was used for statistical signif-
icance. Statistical analyses were conducted using SPSS ver-
sion 16.0.
Results
Table 1 provides the descriptive statistics and genotypic
frequencies for the sample. Age and body size (height,
weight, and BMI) did not differ by sex. Mean height and
weight of both boys and girls approximated the 50th per-
centile of the CDC growth charts. The mean BMI of boys
approximated the 50th percentile, whereas the mean value
for girls approximated the 75th percentile. There were sig-Cardiovascular Diabetology 2009, 8:14 http://www.cardiab.com/content/8/1/14
Page 4 of 8
(page number not for citation purposes)
nificant sex differences for % body fat and BP, as girls had
higher % body fat and DBP and MAP (p < 0.05). The fre-
quency of ACE I/D genotypes did not differ by sex with the
ID genotype being the most frequent (40.1%). The ACE I/
D genotypes were not found to be in HW equilibrium (p
< 0.022) for this sample of children.
The physical characteristics of the subjects grouped by
ACE I/D genotype are shown in Table 2. The physical
characteristics of the sample do not differ by genotype,
except for body mass and fat-free mass (p < 0.05). On
average, individuals with the ACE ID genotype were sig-
nificantly heavier than those with the ACE II genotype.
When dividing the groups by D allele carriers, those indi-
viduals possessing a D allele were heavier than II individ-
uals with body mass, BMI, and fat-free mass being
statistically significant (p < 0.05). Resting BP values did
not differ by genotype.
Partial correlations between measures of adiposity and BP
for the total sample and grouped by genotype are shown
in Table 3. In the total sample, correlations between % fat
and SBP, DBP and MAP were 0.46, 0.30, and 0.42, respec-
tively. Although not significantly different, the ACE ID
Table 1: Physical characteristics of the sample
Characteristics Males (n = 77) Females (n = 75) Total (n = 152)
Age (yrs) 7.3 (2.0) 7.4 (2.1) 7.3 (2.0)
2.9–11.9
Ht (cm) 124.0 (13.0) 123.8 (13.3) 123.9 (13.1)
97.2–161.5
Body mass (kg) 25.4 (7.8) 26.3 (8.9) 25.9 (8.3)
13.6–60.1
BMI (kg/m2) 16.2 (2.4) 16.7 (2.8) 16.5 (2.6)
10.7–29.1
% body fat 24.0 (7.3)* 29.6 (8.0) 26.8 (8.1)
11.7–51.6
SBP (mmHg) 104.0 (8.4) 105.4 (9.0) 104.7 (8.7)
88.0–133.0
DBP (mmHg) 68.7 (6.8)* 71.2 (6.9) 70.0 (6.9)
56.0–100.0
MAP (mmHg) 80.5 (6.4)* 82.6 (6.8) 81.5 (6.7)
69.3–111.0
ACE D/D, n (%) 23 (29.9) 23 (30.7) 46 (30.3)
ACE I/D, n (%) 29 (37.6) 32 (42.6) 61 (40.1)
ACE I/I, n (%) 25 (32.5) 20 (26.7) 45 (29.6)
Values are mean (SD) for boys and girls, with the total sample also showing the range of values
*P < 0.05 for sex difference
Ht, height; BMI, body mass index; WC, waist circumference; % body fat, percent body fat determined by dual energy x-ray absorbtiometry; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure
Table 2: Physical characteristics of the sample by ACE I/D genotype
Characteristics ACE DD (n = 46) ACE ID (n = 61) ACE II (n = 45) D carriers (n = 107)
1Body mass (kg) 25.5 (0.8) 27.1 (0.7)* 24.4 (0.8)* 26.4 (0.5)#
1BMI (kg/m2) 16.4 (0.4) 16.9 (0.3) 15.8 (0.4) 16.7 (0.2)#
1% body fat 27.3 (1.1) 26.8 (1.0) 26.0 (1.1) 27.0 (0.7)
1FM-DXA (kg) 7.5 (0.6) 7.8 (0.5) 6.7 (0.6) 7.7 (0.4)
1FFM-DXA (kg) 18.1 (0.3)a 19.2 (0.3)a 17.9 (0.3)a 18.7 (0.2)#
2SBP (mmHg) 104.6 (1.1) 104.8 (1.0) 104.5 (1.1) 104.7 (0.8)
2DBP (mmHg) 70.5 (0.9) 70.0 (0.8) 69.4 (0.9) 70.2 (0.6)
2MAP (mmHg) 81.9 (0.8) 82.6 (0.7) 81.1 (0.8) 81.7 (0.5)
Values are estimated mean (SE) for each group. BMI, body mass index; WC, waist circumference; % body fat, percent body fat determined by dual 
energy x-ray absorbtiometry; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure
1 controlled for age and sex
2 controlled for age, sex, and height
* P < 0.05 for group difference between ID and II
# P ≤ 0.05 for group difference between D carriers and II
a P < 0.05 for group difference between ID and both DD and IICardiovascular Diabetology 2009, 8:14 http://www.cardiab.com/content/8/1/14
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genotype had the highest correlations (0.41 to 0.65) com-
pared to the other two genotypes (0.19 to 0.38). When
grouped by presence of a D allele, the D carriers showed
slightly higher correlations compared to II but the differ-
ences were not statistically significant as determined by
the Fisher z-transformation.
In general, overfat children had higher BP than normal fat
children (SBP: 109.4 ± 1.0 vs 101.6 ± 0.8 mmHg, DBP:
72.7 ± 0.8 vs. 68.2 ± 0.9 mmHg, and MAP: 84.9 ± 1.0 vs.
79.4 ± 0.8 mmHg, respectively; p < 0.05)(data not
shown). Approximately 42% of subjects carrying the D
allele were overfat compared to 33% in the normal fat
group (p = 0.37). When the sample was analyzed by com-
bined ACE I/D genotype and body fat groups, there was a
significant main effect on SBP (p = 0.005) (Table 4) and
MAP (p = 0.04) (Figure 1). Post-hoc analysis revealed that
the high risk group (ACE D carrier and overfat) had higher
SBP and MAP compared to the ACE II and normal fat
group and the ACE D carrier and normal fat.
Discussion
Although there is currently considerable interest in the
genetics of complex human traits such as BP and other
CVD risk factors, few studies have examined the associa-
tion between candidate genes and CVD risk factors in chil-
dren. This study provides information on the ACE I/D
genotype, adiposity, and BP in a small sample of children.
The results indicate that the D-carriers of the ACE I/D gen-
otype show higher BMI and the overfat D-carriers possess
higher BP phenotypes compared to the normal fat sub-
jects.
Given the pediatric obesity epidemic and its related co-
morbidities including elevated BP, there is considerable
interest in the causes and etiology of these phenotypes.
Although primarily known for its role in BP regulation,
ACE has also been shown to be produced in human adi-
pose tissue [28,29]. A study in mice found that ACE-/- mice
weighed less and had less body fat, especially abdominal
fat, compared to wild-type mice [30]. Our results in
human children show that D carriers were heavier than II
individuals with differences in body mass, BMI, and fat-
free mass being statistically significant. These results are in
accordance with other studies mentioned below that indi-
cate small effects that may be age- and sex-specific. Unfor-
tunately, we could not examine age- and sex-specific
differences due to small sample size. In one study, the D
allele was associated with higher BMI and waist circumfer-
ence in 4–6 year old girls that explained 2–4% of the phe-
notypic variance; but with lower BMI in boys aged 1–2
years that explained 17% of the phenotypic variance [10].
In a study of Greek adolescents (aged 11–18 years), it was
found that the D allele was associated with increased sub-
cutaneous fat in females only, and this association was
additive with phenotypic values of herterozygotes
between those of the two homozygotes [11]. In adults, the
association of the ACE genotype and adiposity has been
found to be age-related as well. A study of Italian men
found the association of BMI and waist circumference
with age was significantly larger in individuals with the
DD genotype [6]. Furthermore, overweight and abdomi-
nal adiposity was found more frequently in men with the
DD genotype (OR = 1.8), especially among older men. For
men evaluated over 20 years, those with the DD genotype
had a larger age-adjusted weight gain (1.5 kg), risk of
being overweight (RR = 2.3), and change in diastolic BP
(+3 mmHg) compared to the ID or II genotypes [6].
Although the ACE gene is an obvious candidate gene for
BP because of its role in the RAA system, results of associ-
ation studies are equivocal. For example, a meta-analysis
of 23 case-control studies found no significant association
between the ACE D allele and hypertension (OR 1.10,
95% CI: 0.95–1.27) [31], and a review of studies between
1997 and 2005 involving ACE and hypertension found 12
positive and 14 negative studies in humans [32]. It has
been suggested that the equivocal results may be because
ACE polymorphisms play a secondary rather than primary
role in hypertension [32], or is due to BP being expressed
dichotomously (hypertension vs. normotensive) rather
than as a continuous quantitative trait [31]. A recent case-
control study found that subjects with the ACE DD geno-
type were 1.6 times more likely to be hypertensive than
carriers of the I allele, and that 15% of all cases of hyper-
tension could be attributed to the ACE DD genotype [33].
In both cases and controls, adjusted SBP and DBP were
4.6 and 3.3 mmHg higher in DD individuals than the
other two genotypes, respectively [33]. Despite the recent
findings, the current evidence indicates any effect of the
ACE D allele on the risk of hypertension in adults is small
to moderate at best. It is also possible that ACE I/D has
Table 3: Partial correlations, controlling for age, sex, and height, 
between percent body fat and blood pressure by genotype in 
young children
Total
(n = 152)
ACE DD
(n = 46)
ACE ID
(n = 61)
ACE II
(n = 45)
D carriers
(n = 107)
Percent Body Fat
SBP 0.46* 0.19 0.65* 0.41* 0.48*
DBP 0.30* 0.20 0.41* 0.16 0.34*
MAP 0.42* 0.24 0.57* 0.31* 0.46*
*P < 0.05 for correlation.
SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, 
mean arterial pressure.Cardiovascular Diabetology 2009, 8:14 http://www.cardiab.com/content/8/1/14
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more of an influence on ambulatory BP or BP response to
stress (exercise or undue stress) rather than resting BP.
Although the results of previous studies in youth are
mixed, our results are generally consistent with the major-
ity of these studies showing no significant association
between ACE I/D genotype and BP in youth [9,12,34,35].
For example, Bloem et al found no direct significant asso-
ciation between longitudinal BP and ACE I/D genotype
[9]. However, they did find an indirect relationship as the
ACE I/D genotype was associated with plasma ACE activ-
ity which in turn was associated with both mean longitu-
dinal SBP and DBP [9]. Thus, future association studies
involving ACE I/D genotype and BP should also measure
plasma ACE levels, since the ACE I/D genotype only serves
as a proxy for ACE levels and this relationship may not be
strong in each individual. On the other hand, studies
showing a positive association between ACE I/D genotype
and BP in youth reveal the association may be sex-
dependent [13,36,37]. A six-year longitudinal study of
more than 3500 6–18 year olds found that boys with the
ACE DD genotype had significantly higher weight-
Differences in mean arterial pressure (MAP) for groups based on combined ACE I/D genotype and body fat category Figure 1
Differences in mean arterial pressure (MAP) for groups based on combined ACE I/D genotype and body fat 
category. * P < 0.05 for difference between II normal fat and D carrier overfat. # P < 0.05 for difference between D carrier 
normal fat and D carrier overfat.
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Table 4: Mean blood pressure values for groups based on combined ACE I/D genotype and body fat category
ACE genotype II D carriers
Percent body fat category Normal fat
(n = 30)
Overfat
(n = 15)
Normal fat
(n = 62)
Overfat
(n = 45)
SBP (mmHg) 103.2 (1.3)* 105.7 (1.9) 102.6 (0.9)# 108.1 (1.1)*#
DBP (mmHg) 68.6 (1.1) 70.2 (1.6) 69.5 (0.8) 71.4 (1.0)
SBP, systolic blood pressure; DBP, diastolic blood pressure.
* P < 0.05 for difference between II normal fat and D carrier overfat.
# P < 0.05 for difference between D carrier normal fat and D carrier overfat.Cardiovascular Diabetology 2009, 8:14 http://www.cardiab.com/content/8/1/14
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adjusted SBP than the other ACE genotypes [13]. In a case-
control study of hypertension in adolescents, a significant
dominant effect of ACE D alleles on SBP was found in
boys only [36]. These results mirror those in adults, which
show the association between BP and the ACE I/D geno-
type may be sex dependent [31,38]. Unfortunately, our
sample was not large enough to conduct sex-specific anal-
yses.
Another purpose of this paper was to examine if the ACE
I/D genotype modified the relationship between adipos-
ity and BP. Our results showing a moderate correlation
between adiposity and BP and differences between overfat
and normal fat youth confirm previous work [15,39].
However, there remains unexplained phenotypic varia-
tion and considerable variation in BP among individuals
with similar levels of adiposity. To our knowledge, this is
the first study to examine if the association between adi-
posity and BP is modified by ACE genotype (or any other
candidate gene) in children, although a recent study of
292 eight-year-old children found that the magnitude of
the association between adiposity and insulin resistance
and triglycerides was stronger in ACE DD subjects com-
pared to II or ID subjects [40]. Altered levels of ACE
caused by obesity have been previously suggested as a
potential pathway through which obesity leads to the ele-
vation of BP in adults [41]. A case-control study in adults
found that the DD genotype had 2.5-fold odds of hyper-
tension compared to the II group [42]. However, the addi-
tive effects of the ACE D allele and BMI increased the
proportion of hypertensive individuals from 40% in non-
obese II and ID individuals to 60% in the non-obese DD
group and 86% in the obese DD group [42]. Our results
offer some confirmation of these findings in that youth
who possessed the D-allele and were overfat had signifi-
cantly higher BP compared to the normal fat youth in
either genotype. Thus, it appears that obesity may
enhance the expression of ACE I/D genotype differences
and lead to elevated BP and perhaps the metabolic syn-
drome.
Conclusion
The role of ACE I/D genotype on adiposity and BP pheno-
types of children are important to consider in the context
of complex, multi-factorial phenotypes. First, these traits
are not monogenic, and therefore other candidate genes
influence these traits as well. Second, adverse exposure to
other environmental factors may also be important to
consider. However, we did show that BP was adversely
influenced in the overfat D-carriers. Finally, it is possible
that ACE I/D may influence these traits differently at vari-
ous lifestages. Given the paucity of data in the area of
genetics and pediatric health and the relative importance
of understanding the role of the genome in human health
and disease, additional study is warranted in this emerg-
ing field of study.
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